ShareHope Medicine Co., Ltd. (TPEX:8403)
Taiwan · Delayed Price · Currency is TWD 22.60
+0.15 (0.67%)
At close: Mar 27, 2026
ShareHope Medicine Revenue
In the year 2025, ShareHope Medicine had annual revenue of 4.36B TWD with 0.74% growth. ShareHope Medicine had revenue of 1.13B in the quarter ending December 31, 2025, with 1.29% growth.
Revenue
4.36B
Revenue Growth
+0.74%
P/S Ratio
0.71
Revenue / Employee
36.93M
Employees
118
Market Cap
3.11B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.36B | 32.04M | 0.74% |
| Dec 31, 2024 | 4.33B | 452.45M | 11.68% |
| Dec 31, 2023 | 3.87B | -263.75M | -6.38% |
| Dec 31, 2022 | 4.14B | 287.10M | 7.46% |
| Dec 31, 2021 | 3.85B | -248.85M | -6.07% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals | 19.01B |
| PharmaEssentia | 15.63B |
| Syngen Biotech | 2.14B |
| Apex Biotechnology | 1.94B |
| Maywufa Company | 1.58B |
| SYN-TECH Chem. & Pharm. | 1.30B |
| WeLeader Biomedical | 1.11B |
| Intech Biopharm | 107.53M |